68Ga-NOTA-BBN-RGD

N/A

Report date: 2025/11/20 16:01:01

NME

Base Information

Drug Name68Ga-NOTA-BBN-RGD

Drug Alias Name68Ga-NOTA-BBN-RGD

ClassificationDiagnostic agent (In vivo)Radiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Gallium > 68Ga +[5]

Mechanisms of ActionGastrin releasing peptide receptor modulatorsIntegrin alpha-V/beta-3 modulators

TargetsGastrin releasing peptide receptorIntegrin alpha-V/beta-3

Therapy Area/IndicationsProstatic NeoplasmsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPending

Originator CompaniesPeking Union Medical College Hospital

China Registration ClassN/A

Develop Information

Active CompaniesPeking Union Medical College Hospital

Inactive CompaniesN/A

Active IndicationsProstatic NeoplasmsBreast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A